15 Results for "

F 16

" in MedChemExpress (MCE) Product Catalog:
Products (15)

15 Results for "F 16" in MCE Product Catalog:

Cat. No.: HY-100395
CAS No.: 36098-33-6
Purity:  99.94%
F16 is a mitochondrial permeability transition pore (PTP) modulator with an EC50 of 30 μM in mice. F16 promotes PTP opening, accumulates in cancer cell mitochondria, and induces mitochondrial depolarization, swelling, cristae disruption, outer membrane rupture, ATP depletion, reactive oxygen species (ROS) production, cytochrome c release and mitochondrial uncoupling. F16 induces cell cycle arrest at the G1 (occasionally G2) phase, reduces the phosphotyrosine content of Neu, as well as the levels of phosphorylated PKB/Akt and phosphorylated MAP kinase, downregulates the protein expression levels of Neu and PKB, triggers apoptosis in cells with moderate Bcl-2 expression, and induces necrosis in cells with overexpressed Bcl-2. F16 can be used in research related to breast cancer and gastric cancer .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P99395
CAS No.: 1826831-79-1
Synonyms: JNJ 56022473; CSL 362

Target:  

Interleukin Related

Research Areas:  

Cancer

Talacotuzumab (JNJ 56022473; CSL 362) is an IgG1-type fully humanized, CD123-neutralizing monoclonal antibody containing a modified Fc structure. Talacotuzumab has KDs of 0.43 nM, 188 nM, 46 nM, 16.8 nM for CD123, CD32b/c, CD16-158F, CD16-158V, respectively. Talacotuzumab inhibits IL-3 binding to CD123, antagonizing IL-3 signaling in target cells. Talacotuzumab has mutated the Fc region to increase affinity for CD16 (FcγRIIIa), thereby enhancing antibody-dependent cell-mediated cytotoxicity (ADCC). Talacotuzumab is highly effective in vivo reducing leukemic cell growth in acute myeloid leukemia (AML) xenograft mouse models .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P73634
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: SNAP25; SEC9; Prev. SNAP; Synaptosomal-Associated Protein, 25kDa; SNAP-25; SUP; Synaptosomal-Associated Protein 25; Synaptosomal-Associated 25 KDa Protein; DJ1068F16.2; Synaptosome Associated Protein 25kDa; BA416N4.2; Super Protein; RIC-4; DEE117; RIC4; C
Species:  
Human
Source:  
E. coli
loading...
    loading...
Cat. No.: HY-124866
CAS No.: 922507-80-0
Purity:  ≥98.0%
Target:  

PDI

Research Areas:  

Neurological Disease

PDI-IN-3 (compound 16F16) is a protein disulfide isomerase (PDI) inhibitor. PDI-IN-3 inhibits cell viability .
loading...
    loading...
Cat. No.: HY-171544
Synonyms: AGS-16M8F
AGS-16C3F is an antibody-drug conjugate (ADC) targeting ENPP3. AGS-16C3F is composed of ENPP3-targeting Anti-ENPP3/CD203c Antibody (HY-P990315) linked to Monomethyl auristatin F (HY-15579) via a linker. AGS-16C3F has anti-tumor activity and can be used in the study of metastatic renal cell carcinoma (mRCC) .
loading...
    loading...
Cat. No.: HY-P990315
Synonyms: AGS-16C

Target:  

Inhibitory Antibodies

Research Areas:  

Inflammation/Immunology

Anti-ENPP3/CD203c Antibody (AGS-16C3F antibody) is a humanized antibody expressed in CHO cells, targeting ENPP3/CD203c. Anti-ENPP3/CD203c Antibody contains a huIgG2 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 154.04 kDa. The isotype control for Anti-ENPP3/CD203c Antibody can refer to Human IgG2 kappa, Isotype Control (HY-P99002).
loading...
    loading...
Cat. No.: HY-156752
CAS No.: 452919-90-3
Purity:  99.68%
Target:  

Drug Metabolite

Research Areas:  

Others

Cyclosiversioside F 16,25-diacetate (Compound 6), a glycoside, is an alkaline hydrolysis product of Acetyl Derivative (Compound 2) .
loading...
    loading...
Cat. No.: HY-157292
CAS No.: 3002962-69-5
Research Areas:  

Cancer

2E-3-F16 is a anticancer agent. 2E-3-F16 exhibits tumor cell selectivity between NCI-H446 cancer cells and HBE cells. 2E-3-F16 enhances the sensitivity of A549 cells to Cisplatin (HY-17394) .
loading...
    loading...
Cat. No.: HY-100395R
CAS No.: 36098-33-6
F16 (Standard) is the analytical standard of F16 (HY-100395). This product is intended for research and analytical applications. F16 is a mitochondrial permeability transition pore (PTP) modulator with an EC50 of 30 μM in mice. F16 promotes PTP opening, accumulates in cancer cell mitochondria, and induces mitochondrial depolarization, swelling, cristae disruption, outer membrane rupture, ATP depletion, reactive oxygen species (ROS) production, cytochrome c release and mitochondrial uncoupling. F16 induces cell cycle arrest at the G1 (occasionally G2) phase, reduces the phosphotyrosine content of Neu, as well as the levels of phosphorylated PKB/Akt and phosphorylated MAP kinase, downregulates the protein expression levels of Neu and PKB, triggers apoptosis in cells with moderate Bcl-2 expression, and induces necrosis in cells with overexpressed Bcl-2. F16 can be used in research related to breast cancer and gastric cancer .
loading...
    loading...
Cat. No.: HY-149002
CAS No.: 3031403-77-4
Target:  

Topoisomerase Apoptosis

Research Areas:  

Cancer

Topoisomerase I/II inhibitor 4 (compound F16) is a potent topoisomerase I (Topo I) and II (Topo II) dual inhibitor. Topoisomerase I/II inhibitor 4 inhibits cell proliferation, invasion and migration and induces apoptosis. Topoisomerase I/II inhibitor 4 can be used for liver cancer research .
loading...
    loading...
Cat. No.: HY-D2310
CXCR2 Probe 1 (Compound [18F]16b) is a selective ligand for CXCR2 and is a radiotracer for PET imaging of neutrophils in inflammatory diseases .
loading...
    loading...
Cat. No.: HY-W110066
CAS No.: 14916-87-1
Synonyms: F16CuPc (purified by sublimation)
Target:  

MOFs

Research Areas:  

Others

Copper hexadecafluorophthalocyanine (F16CuPc (purified by sublimation)) is a metal-organic framework (MOF).
loading...
    loading...
Cat. No.: HY-P992067

Research Areas:  

Others

Anti-Human/Monkey NKG2D Antibody (16F16) is an antibody targeting human/monkey NKG2D. The isotype control for Anti-Human/Monkey NKG2D Antibody (16F16) can be referenced as Human IgG4 kappa, Isotype Control (HY-P99003).
loading...
    loading...
Cat. No.: HY-184280
CAS No.: 3128226-38-7
Research Areas:  

Cancer

Anticancer agent 329 is a mitochondria-targeted Podophyllotoxin (HY-15552) derivative conjugated with F16 (HY-100395), and also acts as an anticancer agent. Anticancer agent 329 accumulates in mitochondria and induces Apoptosis in a concentration-dependent manner. Anticancer agent 329 can be used in the research of liver cancer, colorectal cancer, non-small cell lung cancer and breast cancer .
loading...
    loading...
Cat. No.: HY-P81519
Synonyms: 6-bisphosphatase 1 antibody; 6-bisphosphate 1-phosphohydrolase 1 antibody; D fructose 1 6 bisphosphate 1 phosphohydrolase 1 antibody; D-fructose-1 antibody; EC 3.1.3.11 antibody; F16P1_HUMAN antibody; FBP antibody; FBP 1 antibody; FBP1 antibody; FBPase 1 antibody; Fructose 1 6 bisphosphatase 1 antibody; Fructose bisphosphatase 1 antibody; Fructose-1 antibody; Growth inhibiting protein 17 antibody; Liver fructose bisphosphatase antibody;

Host:  

Rabbit

Application:  

WB, IHC-P, ICC/IF

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
  • 1